Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications
Patrick Wuchter(Heidelberg University), Michael Schmitt(German Cancer Research Center), Ingo Müller(Universität Hamburg), Eike C. Buss(Heidelberg University), Matthias Renner(Paul Ehrlich Institut), Karen Bieback(Heidelberg University), Wolfgang Wagner(Landwirtschaftliches Technologiezentrum Augustenberg), Martin Bornhäuser(Technische Universität Dresden), Petra Pavel(Heidelberg Institute for Stem Cell Technology and Experimental Medicine), Torsten Tonn(Goethe University Frankfurt), Roland Meisel(Düsseldorf University Hospital), Peter Lang(STZ eyetrial), Rainer Saffrich(Heidelberg University), Anthony D. Ho(Heidelberg University), Hubert Schrezenmeier(German Red Cross), Halvard Bönig(Goethe University Frankfurt), Georg Malcherek(Heidelberg University), Lutz Müller(Roche (Switzerland)), Patrick Horn(Heidelberg University), Markus Rojewski(University Hospital Ulm), Anita Schmitt(Heidelberg University), Ralf Sanzenbacher(Paul Ehrlich Institut)
Cited by 152
Related Papers
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
|Blood|2004|1.6k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k